[Treatment of severe chronic pains with a combination of thymoleptics and neuroleptics (author's transl)].
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002997:Clomipramine / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008728:Methotrimeprazine / Q000627:therapeutic use; D008875:Middle Aged; D009020:Morphine / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications; D010146:Pain / Q000188:drug therapy*; D010208:Papaverine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000928:Antidepressive Agents; D004338:Drug Combinations; D014149:Tranquilizing Agents; D009020:Morphine; D001285:Atropine; D008728:Methotrimeprazine; D010208:Papaverine; D006220:Haloperidol; D002997:Clomipramine; D007099:Imipramine; D002746:Chlorpromazine
Die Behandlung schwerer, chronischer Schmerzzustände mit einer Kombination von Thymoleptika und Neuroleptika